三阴性乳腺癌中的肿瘤浸润淋巴细胞：一种超越预后用途的生物标志物？ - Suppr

Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?

作者信息

Tsoutsou Pelagia G, Bourhis Jean, Coukos George

机构信息

Hôpital du Valais-Centre Hospitalier du Valais Romand, Hôpital de Sion, Sion; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

出版信息

J Clin Oncol. 2015 Apr 10;33(11):1297-8. doi: 10.1200/JCO.2014.59.2808. Epub 2015 Mar 9.

DOI:10.1200/JCO.2014.59.2808

PMID:25753438

Abstract

摘要

相似文献

Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?

J Clin Oncol. 2015 Apr 10;33(11):1297-8. doi: 10.1200/JCO.2014.59.2808. Epub 2015 Mar 9.

Tumor-infiltrating lymphocytes in breast cancer: ready for prime time?

J Clin Oncol. 2015 Apr 10;33(11):1298-9. doi: 10.1200/JCO.2014.59.7286. Epub 2015 Mar 9.

Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer.

J Clin Oncol. 2014 Sep 20;32(27):2935-7. doi: 10.1200/JCO.2014.56.7677.

Reply to A. Ocaña et al and P.G. Tsoutsou et al.

J Clin Oncol. 2015 Apr 10;33(11):1299-300. doi: 10.1200/JCO.2014.59.9423. Epub 2015 Mar 9.

Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes.

Virchows Arch. 2017 Apr;470(4):381-389. doi: 10.1007/s00428-017-2083-5. Epub 2017 Feb 9.

Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.

Ann Surg Oncol. 2016 Jul;23(7):2242-8. doi: 10.1245/s10434-016-5173-8. Epub 2016 Mar 10.

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.

Oncotarget. 2017 Feb 28;8(9):15584-15592. doi: 10.18632/oncotarget.14698.

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.

BMC Cancer. 2018 Jan 2;18(1):4. doi: 10.1186/s12885-017-3916-y.

The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).

Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9.

Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.

Clin Cancer Res. 2016 Dec 1;22(23):5747-5754. doi: 10.1158/1078-0432.CCR-15-2338. Epub 2016 May 17.

引用本文的文献

Artificial intelligence reveals features associated with breast cancer neoadjuvant chemotherapy responses from multi-stain histopathologic images.

NPJ Precis Oncol. 2023 Jan 27;7(1):14. doi: 10.1038/s41698-023-00352-5.

Cancer Sci. 2020 Oct;111(10):3493-3502. doi: 10.1111/cas.14570. Epub 2020 Aug 4.

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer.

Oncol Lett. 2019 Feb;17(2):2177-2186. doi: 10.3892/ol.2018.9853. Epub 2018 Dec 19.

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.

Front Oncol. 2018 Dec 12;8:609. doi: 10.3389/fonc.2018.00609. eCollection 2018.

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.

Breast Cancer Res. 2016 Dec 3;18(1):121. doi: 10.1186/s13058-016-0783-4.

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Breast Cancer Res. 2016 Feb 16;18(1):21. doi: 10.1186/s13058-016-0682-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献